SCHEMBL24127614

SCHEMBL24127614

C=C(C)C1CCN(C2CCB(C#N)CC2)CC1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25113273 0.79 ALDH1A1 (0.34) —
SCHEMBL19562614 0.71 GPR119 (0.35) —
SCHEMBL22995951 0.64 — —
SCHEMBL29316595 0.62 HTR6 (0.49) RAB9A
SCHEMBL21078296 0.62 RAB9A (0.39) RAB9A
SCHEMBL15223506 0.62 NCF1 (0.37) —
SCHEMBL22988889 0.60 LMNA (0.33) —
SCHEMBL20842192 0.60 LMNA (0.35) RAB9A
SCHEMBL21548010 0.60 CHRM2 (0.42) —
SCHEMBL513994 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021257736-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS Revolution Medicines, Inc. (US) 2021-12-23 — — WO disclosed
Send feedback